Concurrent Sexually Transmitted Infections (STIs) in sex partners of patients with selected STIs: Implications for patient-delivered partner therapy

Clinical Infectious Diseases

Volumn 40, Issue 6, 2005, Pages 787-793

  Stekler, Joanne ^a   Bachmann, Laura ^c   Brotman, Rebecca M ^d   Erbelding, Emily J ^d   Lloyd, Laura V ^e   Rietmeijer, Cornelis A ^e   Handsfield, H Hunter ^a,b   Holmes, King K ^a   Golden, Matthew R ^a,b,f  

^a UNIVERSITY OF WASHINGTON   (United States)

^b PUBLIC HEALTH SEATTLE AND KING COUNTY   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e DENVER PUBLIC HEALTH   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; BISEXUALITY; CHLAMYDIASIS; DISEASE ASSOCIATION; FEMALE; GONORRHEA; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PATIENT DELIVERED PARTNER THERAPY; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL; REVIEW; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; THERAPY; TRICHOMONIASIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; CONTACT TRACING; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; SEXUAL PARTNERS; SEXUALLY TRANSMITTED DISEASES;

EID: 14944356030     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/428043     Document Type: Review

References (20)

1. Hogben M, McCree DH, Golden MR. Patient-delivered partner therapy for sexually transmitted diseases as practiced by US physicians. Sex Transm Dis 2005; 32:101-5.
2. Golden MR, Whittington WL, Gorbach PM, Coronado N, Boyd MA, Holmes KK. Partner notification for chlamydial infections among private sector clinicians in Seattle-King County: a clinician and patient survey. Sex Transm Dis 1999; 26:543-7.
3. St Lawrence JS, Montano DE, Kasprzyk D, Phillips WR, Armstrong K, Leichliter JS. STD screening, testing, case reporting, and clinical and partner notification practices: a national survey of US physicians. Am J Public Health 2002; 92:1784-8.
4. Golden MR, Hogben M, Handsfield HH, St Lawrence JS, Potterat JJ, Holmes KK. Partner notification for HIV and STD in the United States: low coverage for gonorrhea, chlamydial infection, and HIV. Sex Transm Dis 2003; 30:490-6.
5. van de Laar MJW, Termorshuizen F, van den Hoek A. Partner referral by patients with gonorrhea and chlamydial infection: case-finding observations. Sex Transm Dis 1997; 24:334-42.
6. Mathews C, Coetzee N, Zwarenstein M, et al. A systematic review of strategies for partner notification for sexually transmitted diseases, including HIV/AIDS. Int J STD AIDS 2002; 13:285-300.
7. Whittington WL, Kent C, Kissinger P, et al. Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study. Sex Transm Dis 2001; 28:117-23.
8. Institute of Medicine (IOM). Eng TR, Butler WT, eds. The hidden epidemic: confronting sexually transmitted diseases. Washington, DC: National Academy Press, 1997.
9. Golden MR, Whittington WLH, Handsfield, et al. Partner management for gonococcal and chlamydial infection: expansion of public health services to the private sector and expedited sex partner treatment through a partnership with commercial pharmacies. Sex Transm Dis 2001; 28:658-65.
10. Schillinger JA, Kissinger P, Calvet H, et al. Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial. Sex Transm Dis 2003; 30:49-56.
11. Ramstedt K, Forssman L, Johannisson G. Contact tracing in the control of genital Chlamydia trachomatis infection. Int J STD AIDS 1991; 2:116-8.
12. Kissinger P, Brown R, Reed K, et al. Effectiveness of patient delivered partner medication for preventing recurrent Chlamydia trachomatis. Sex Transm Infect 1998; 74:331-3.
13. Golden MR, Whittington WLH, Handsfield HH, et al. Impact of expedited sex partner treatment on recurrent or persistent gonorrhea or chlamydial infection: a randomized controlled trial. N Engl J Med 2005; 352:676-85.
14. Lyng J, Christensen J. A double-blind study of the value of treatment with a single dose tinidazole of partners to females with trichomoniasis. Acta Obstet Gynecol Scand 1981; 60:199-201.
15. McCree DH, Liddon NC, Hogben M, St Laurence JS. National survey of doctors' actions following the diagnosis of a bacterial STD. Sex Transm Infect 2003; 79:254-6.
16. Klausner JD, Chaw JK. Patient-delivered therapy for chlamydia: putting research into practice. Sex Transm Dis 2003; 30:509-11.
17. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Recomm Rep 2002; 51(RR-6):1-78.
18. Rustomjee R, Kharsany AB, Connolly CA, Karim SS. A randomized controlled trial of azithromycin versus doxycycline/ciprofloxacin for the syndromic management of sexually transmitted infections in a resource-poor setting. J Antimicrob Chemother 2002; 49:875-8.
19. Swanston WH, Prabhakar P, Barrow L, Mahabir BS, Furlonge C. Single dose (direct observed) azithromycin therapy for Neisseria gonorrhoeae and Chlamydia trachomatis in STD clinic attenders with genital discharge in Trinidad and Tobago. West Indian Med J 2001; 50:198-202.
20. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2002 supplement: Gonococcal Isolate Surveillance Project (GISP) annual report 2002. Atlanta: US Department of Health and Human Services, 2003.